View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
NLG MCL-2 regimen - Cytarabine 3000 / Rituximab 375, Mantle Cell Lymphoma, cycle 2 and 4, younger than 60 years
Protocol-ID: 290 V1.3 (Mini), NLG MCL-2 regimen, C2+4, CYTA3000/RITU375, below 60Indication(s)
- Mantle Cell Lymphoma; ICD-10 C83.1
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.08.2015